亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。
Novel Orally Available Treatment for Metabolic Syndrome & T2D
技術優勢
- Identified, designed and developed merged pharmacophore for sEH/PPAR dual modulators as a unique therapeutic approach- Novel dual modulators are orally available- Favorable absorption, distribution, metabolism and excretion properties- Avoid multidrug regimens and associated unpredictable drug-drug interactions- Modulation of PPAR╬│ regulates lipid metabolism, glucose homeostasis, anti-inflammatory processes- Modulating sEH/ has multiple cardio and kidney protective properties- Lead candidate decreases blood glucose and insulin resistance, improves heart function, prevents development of hypertension and end organ damage in spontaneously hypertensive obese rats (SHROB)
詳細技術說明
None
國家/地區
美國
欲了解更多信息，請點擊 這裡
